-
1
-
-
0035811625
-
Hepatitis C virus infection
-
Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001 345 : 41 52.
-
(2001)
N Engl J Med
, vol.345
, pp. 41-52
-
-
Lauer, G.M.1
Walker, B.D.2
-
2
-
-
0030752667
-
Hepatitis C virus: Epidemiology and transmission
-
Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997 26 : 521 526.
-
(1997)
Hepatology
, vol.26
, pp. 521-526
-
-
Heintges, T.1
Wands, J.R.2
-
3
-
-
0033382086
-
Epidemiology of hepatitis C in the United States
-
Williams I. Epidemiology of hepatitis C in the United States. Am J Med 1999 107 : 2S 9S.
-
(1999)
Am J Med
, vol.107
-
-
Williams, I.1
-
4
-
-
0037223797
-
Prevalence of hepatitis C among psychiatric patients in the public sector
-
Dinwiddie SH, Shicker L, Newman T. Prevalence of hepatitis C among psychiatric patients in the public sector. Am J Psychiatry 2003 160 : 172 174.
-
(2003)
Am J Psychiatry
, vol.160
, pp. 172-174
-
-
Dinwiddie, S.H.1
Shicker, L.2
Newman, T.3
-
5
-
-
0030880597
-
Hepatitis C virus infection among institutionalised psychiatric patients: A regression analysis of indicators of risk
-
Cividini A, Pistorio A, Regazzetti A, et al. Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk. J Hepatol 1997 27 : 455 463.
-
(1997)
J Hepatol
, vol.27
, pp. 455-463
-
-
Cividini, A.1
Pistorio, A.2
Regazzetti, A.3
-
6
-
-
0027263876
-
Hepatitis B and hepatitis C among institutionalized psychiatric patients in Taiwan
-
Chang TT, Lin H, Yen YS, Wu HL. Hepatitis B and hepatitis C among institutionalized psychiatric patients in Taiwan. J Med Virol 1993 40 : 170 173. (Pubitemid 23169747)
-
(1993)
Journal of Medical Virology
, vol.40
, Issue.2
, pp. 170-173
-
-
Chang, T.-T.1
Lin, H.2
Yen, L.-S.3
Wu, H.-L.4
-
8
-
-
0037179698
-
Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002 347 : 975 982.
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
-
9
-
-
0035934568
-
Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomised trial
-
Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial. Lancet 2001 358 : 958 965.
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
-
10
-
-
0036788338
-
Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C
-
McHutchison JG, Manns M, Patel K, et al. Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C. Gastroenterology 2002 123 : 1061 1069.
-
(2002)
Gastroenterology
, vol.123
, pp. 1061-1069
-
-
McHutchison, J.G.1
Manns, M.2
Patel, K.3
-
12
-
-
18344413225
-
Ribavirin may be an important factor in IFN-induced neuropsychiatric effects
-
Asnis GM, De La GR, Miller AH, Raison CL. Ribavirin may be an important factor in IFN-induced neuropsychiatric effects. J Clin Psychiatry 2004 65 : 581 582.
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 581-582
-
-
Asnis, G.M.1
De La, G.R.2
Miller, A.H.3
Raison, C.L.4
-
14
-
-
0642336255
-
Hepatitis C, alpha interferon, anxiety and depression disorders: A prospective study of 71 patients
-
Gohier B, Goeb JL, Rannou-Dubas K, Fouchard I, Cales P, Garre JB. Hepatitis C, alpha interferon, anxiety and depression disorders: a prospective study of 71 patients. World J Biol Psychiatry 2003 4 : 115 118.
-
(2003)
World J Biol Psychiatry
, vol.4
, pp. 115-118
-
-
Gohier, B.1
Goeb, J.L.2
Rannou-Dubas, K.3
Fouchard, I.4
Cales, P.5
Garre, J.B.6
-
15
-
-
0025921602
-
Persistent neurotoxicity of systemically administered interferon-alpha
-
Meyers CA, Scheibel RS, Forman AD. Persistent neurotoxicity of systemically administered interferon-alpha. Neurology 1991 41 : 672 676.
-
(1991)
Neurology
, vol.41
, pp. 672-676
-
-
Meyers, C.A.1
Scheibel, R.S.2
Forman, A.D.3
-
16
-
-
15244363180
-
Depression during therapy with interferon alpha - How long should an antidepressant treatment last?
-
Nickel T, Sonntag A, Backmund M, Pollmacher T. Depression during therapy with interferon alpha - how long should an antidepressant treatment last? Pharmacopsychiatry 2005 38 : 102 104.
-
(2005)
Pharmacopsychiatry
, vol.38
, pp. 102-104
-
-
Nickel, T.1
Sonntag, A.2
Backmund, M.3
Pollmacher, T.4
-
17
-
-
27944470385
-
Interferon-induced depression and cognitive impairment in hepatitis C virus patients: A 72 week prospective study
-
Reichenberg A, Gorman JM, Dieterich DT. Interferon-induced depression and cognitive impairment in hepatitis C virus patients: a 72 week prospective study. AIDS 2005 3 : S174 8.
-
(2005)
AIDS
, vol.3
, pp. 174-8
-
-
Reichenberg, A.1
Gorman, J.M.2
Dieterich, D.T.3
-
18
-
-
0037308288
-
Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups
-
Schaefer M, Schmidt F, Folwaczny C, et al. Adherence and mental side effects during hepatitis C treatment with interferon alfa and ribavirin in psychiatric risk groups. Hepatology 2003 37 : 443 451.
-
(2003)
Hepatology
, vol.37
, pp. 443-451
-
-
Schaefer, M.1
Schmidt, F.2
Folwaczny, C.3
-
19
-
-
0004235298
-
-
4th edn, American Psychiatric Association. DSM-IV-TR. American Psychiatric Association. Washington, DC
-
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, DSM-IV-TR. American Psychiatric Association. Washington, DC, 2000.
-
(2000)
Diagnostic and Statistical Manual of Mental Disorders
-
-
-
21
-
-
0018425438
-
A new depression scale designed to be sensitive to change
-
Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979 134 : 382 389.
-
(1979)
Br J Psychiatry
, vol.134
, pp. 382-389
-
-
Montgomery, S.A.1
Asberg, M.2
-
22
-
-
0000503515
-
The brief psychiatric rating scale
-
Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep 1962 10 : 799 812.
-
(1962)
Psychol Rep
, vol.10
, pp. 799-812
-
-
Overall, J.E.1
Gorham, D.R.2
-
24
-
-
34247550405
-
Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C
-
Raison CL, Woolwine BJ, Demetrashvili MF, et al. Paroxetine for prevention of depressive symptoms induced by interferon-alpha and ribavirin for hepatitis C. Aliment Pharmacol Ther 2007 25 : 1163 1174.
-
(2007)
Aliment Pharmacol Ther
, vol.25
, pp. 1163-1174
-
-
Raison, C.L.1
Woolwine, B.J.2
Demetrashvili, M.F.3
-
25
-
-
0033054813
-
EASL consensus statement - International consensus conference on hepatitis C
-
EASL
-
EASL. EASL Consensus Statement - International Consensus Conference on Hepatitis C. J Hepatol 1999 30 : 956 961.
-
(1999)
J Hepatol
, vol.30
, pp. 956-961
-
-
-
26
-
-
0031584956
-
Management of hepatitis C: NIH consensus statement
-
NIH
-
NIH. Management of Hepatitis C: NIH Consensus Statement. Hepatology 1997 15 : 1 41.
-
(1997)
Hepatology
, vol.15
, pp. 1-41
-
-
-
27
-
-
0035913229
-
Treatment of chronic hepatitis C in active drug users
-
Davis GL, Rodrigue JR. Treatment of chronic hepatitis C in active drug users. N Engl J Med 2001 345 : 215 217.
-
(2001)
N Engl J Med
, vol.345
, pp. 215-217
-
-
Davis, G.L.1
Rodrigue, J.R.2
-
28
-
-
0035913261
-
Is it justifiable to withhold treatment for hepatitis C from illicit-drug users?
-
Edlin BR, Seal KH, Lorvick J, et al. Is it justifiable to withhold treatment for hepatitis C from illicit-drug users? N Engl J Med 2001 345 : 211 215.
-
(2001)
N Engl J Med
, vol.345
, pp. 211-215
-
-
Edlin, B.R.1
Seal, K.H.2
Lorvick, J.3
-
29
-
-
4544228944
-
Treatment of chronic hepatitis C in patients with drug dependence: Time to change the rules?
-
Schaefer M, Heinz A, Backmund M. Treatment of chronic hepatitis C in patients with drug dependence: time to change the rules? Addiction 2004 99 : 1167 1175.
-
(2004)
Addiction
, vol.99
, pp. 1167-1175
-
-
Schaefer, M.1
Heinz, A.2
Backmund, M.3
-
30
-
-
0037119025
-
Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals
-
Taylor LE, Costello T, Alt E, Yates G, Tashima K. Psychiatric illness and illicit drugs as barriers to hepatitis C treatment among HIV/hepatitis C virus co-infected individuals. AIDS 2002 16 : 1700 1701.
-
(2002)
AIDS
, vol.16
, pp. 1700-1701
-
-
Taylor, L.E.1
Costello, T.2
Alt, E.3
Yates, G.4
Tashima, K.5
-
31
-
-
0033542853
-
Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders
-
Pariante CM, Orru MG, Baita A, Farci MG, Carpiniello B. Treatment with interferon-alpha in patients with chronic hepatitis and mood or anxiety disorders. Lancet 1999 354 : 131 132.
-
(1999)
Lancet
, vol.354
, pp. 131-132
-
-
Pariante, C.M.1
Orru, M.G.2
Baita, A.3
Farci, M.G.4
Carpiniello, B.5
-
32
-
-
33644747709
-
Hepatitis C treatment of veterans with psychiatric illness
-
Rifai MA, Loftis JM, Hauser P. Hepatitis C treatment of veterans with psychiatric illness. Am J Gastroenterol 2006 101 : 673 674.
-
(2006)
Am J Gastroenterol
, vol.101
, pp. 673-674
-
-
Rifai, M.A.1
Loftis, J.M.2
Hauser, P.3
-
33
-
-
36348986800
-
Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: Response and psychiatric side effects
-
Schaefer M, Hinzpeter A, Mohmand A, et al. Hepatitis C treatment in "difficult-to-treat" psychiatric patients with pegylated interferon-alpha and ribavirin: response and psychiatric side effects. Hepatology 2007 46 : 991 998.
-
(2007)
Hepatology
, vol.46
, pp. 991-998
-
-
Schaefer, M.1
Hinzpeter, A.2
Mohmand, A.3
-
34
-
-
0028858952
-
Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness
-
Van Thiel DH, Friedlander L, Molloy PJ, Fagiuoli S, Kania RJ, Caraceni P. Interferon-alpha can be used successfully in patients with hepatitis C virus-positive chronic hepatitis who have a psychiatric illness. Eur J Gastroenterol Hepatol 1995 7 : 165 168.
-
(1995)
Eur J Gastroenterol Hepatol
, vol.7
, pp. 165-168
-
-
Van Thiel, D.H.1
Friedlander, L.2
Molloy, P.J.3
Fagiuoli, S.4
Kania, R.J.5
Caraceni, P.6
-
35
-
-
0036430340
-
A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C
-
Hauser P, Khosla J, Aurora H, et al. A prospective study of the incidence and open-label treatment of interferon-induced major depressive disorder in patients with hepatitis C. Mol Psychiatry 2002 7 : 942 947.
-
(2002)
Mol Psychiatry
, vol.7
, pp. 942-947
-
-
Hauser, P.1
Khosla, J.2
Aurora, H.3
-
36
-
-
0037872269
-
Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy
-
Kraus MR, Schafer A, Faller H, Csef H, Scheurlen M. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J Clin Psychiatry 2003 64 : 708 714.
-
(2003)
J Clin Psychiatry
, vol.64
, pp. 708-714
-
-
Kraus, M.R.1
Schafer, A.2
Faller, H.3
Csef, H.4
Scheurlen, M.5
-
37
-
-
33748257103
-
Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): Results from a prospective study
-
Lieb K, Engelbrecht MA, Gut O, et al. Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFNalpha): results from a prospective study. Eur Psychiatry 2006 21 : 204 210.
-
(2006)
Eur Psychiatry
, vol.21
, pp. 204-210
-
-
Lieb, K.1
Engelbrecht, M.A.2
Gut, O.3
-
38
-
-
0031914489
-
Interferon alpha-induced depression in chronic hepatitis C patients: Comparison between different types of interferon alpha
-
Malaguarnera M, Di FI, Restuccia S, Pistone G, Ferlito L, Rampello L. Interferon alpha-induced depression in chronic hepatitis C patients: comparison between different types of interferon alpha. Neuropsychobiology 1998 37 : 93 7.
-
(1998)
Neuropsychobiology
, vol.37
, pp. 93-7
-
-
Malaguarnera, M.1
Di, F.I.2
Restuccia, S.3
Pistone, G.4
Ferlito, L.5
Rampello, L.6
-
39
-
-
33750342122
-
Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: Comparison between interferon-alpha-2a and interferon-alpha-2b
-
Neri S, Pulvirenti D, Bertino G. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b. Clin Drug Investig 2006 26 : 655 662.
-
(2006)
Clin Drug Investig
, vol.26
, pp. 655-662
-
-
Neri, S.1
Pulvirenti, D.2
Bertino, G.3
-
40
-
-
9944223329
-
Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C
-
Raison CL, Broadwell SD, Borisov AS, et al. Depressive symptoms and viral clearance in patients receiving interferon-alpha and ribavirin for hepatitis C. Brain Behav Immun 2005 19 : 23 7.
-
(2005)
Brain Behav Immun
, vol.19
, pp. 23-7
-
-
Raison, C.L.1
Broadwell, S.D.2
Borisov, A.S.3
-
41
-
-
13844306621
-
Depression during pegylated interferon-alpha plus ribavirin therapy: Prevalence and prediction
-
Raison CL, Borisov AS, Broadwell SD, et al. Depression during pegylated interferon-alpha plus ribavirin therapy: prevalence and prediction. J Clin Psychiatry 2005 66 : 41 8.
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 41-8
-
-
Raison, C.L.1
Borisov, A.S.2
Broadwell, S.D.3
-
42
-
-
0037266123
-
Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: A prospective study
-
Horikawa N, Yamazaki T, Izumi N, Uchihara M. Incidence and clinical course of major depression in patients with chronic hepatitis type C undergoing interferon-alpha therapy: a prospective study. Gen Hosp Psychiatry 2003 25 : 34 8.
-
(2003)
Gen Hosp Psychiatry
, vol.25
, pp. 34-8
-
-
Horikawa, N.1
Yamazaki, T.2
Izumi, N.3
Uchihara, M.4
-
43
-
-
0036186518
-
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
-
Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology 2002 35 : 704 708.
-
(2002)
Hepatology
, vol.35
, pp. 704-708
-
-
Bernstein, D.1
Kleinman, L.2
Barker, C.M.3
Revicki, D.A.4
Green, J.5
-
44
-
-
33646476276
-
Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C
-
Hollander A, Foster GR, Weiland O. Health-related quality of life before, during and after combination therapy with interferon and ribavirin in unselected Swedish patients with chronic hepatitis C. Scand J Gastroenterol 2006 41 : 577 585.
-
(2006)
Scand J Gastroenterol
, vol.41
, pp. 577-585
-
-
Hollander, A.1
Foster, G.R.2
Weiland, O.3
-
45
-
-
31144436818
-
Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan
-
Kang SC, Hwang SJ, Lee SH, Chang FY, Lee SD. Health-related quality of life and impact of antiviral treatment in Chinese patients with chronic hepatitis C in Taiwan. World J Gastroenterol 2005 11 : 7494 7498.
-
(2005)
World J Gastroenterol
, vol.11
, pp. 7494-7498
-
-
Kang, S.C.1
Hwang, S.J.2
Lee, S.H.3
Chang, F.Y.4
Lee, S.D.5
-
46
-
-
33745176622
-
Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with pegylated interferon alpha-2b and ribavirin
-
Mathew A, Peiffer LP, Rhoades K, McGarrity TJ. Improvement in quality of life measures in patients with refractory hepatitis C, responding to re-treatment with pegylated interferon alpha-2b and ribavirin. Health Qual Life Outcomes 2006 4 : 30.
-
(2006)
Health Qual Life Outcomes
, vol.4
, pp. 30
-
-
Mathew, A.1
Peiffer, L.P.2
Rhoades, K.3
McGarrity, T.J.4
-
47
-
-
0035133564
-
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity
-
McHutchison JG, Ware JE Jr., Bayliss MS, et al. The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity. J Hepatol 2001 34 : 140 147.
-
(2001)
J Hepatol
, vol.34
, pp. 140-147
-
-
McHutchison, J.G.1
Ware, Jr.J.E.2
Bayliss, M.S.3
-
48
-
-
84891685662
-
Health benefits of antiviral therapy for mild chronic hepatitis C: Randomised controlled trial and economic evaluation
-
Wright M, Grieve R, Roberts J, Main J, Thomas HC. Health benefits of antiviral therapy for mild chronic hepatitis C: randomised controlled trial and economic evaluation. Health Technol Assess 2006 10 : 1 113.
-
(2006)
Health Technol Assess
, vol.10
, pp. 1-113
-
-
Wright, M.1
Grieve, R.2
Roberts, J.3
Main, J.4
Thomas, H.C.5
-
49
-
-
30544445602
-
Cytokines sing the blues: Inflammation and the pathogenesis of depression
-
Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol 2006 27 : 24 31.
-
(2006)
Trends Immunol
, vol.27
, pp. 24-31
-
-
Raison, C.L.1
Capuron, L.2
Miller, A.H.3
-
51
-
-
0034496202
-
Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy
-
Weissenborn K, Berding G, Kostler H. Altered striatal dopamine D2 receptor density and dopamine transport in a patient with hepatic encephalopathy. Metab Brain Dis 2000 15 : 173 178.
-
(2000)
Metab Brain Dis
, vol.15
, pp. 173-178
-
-
Weissenborn, K.1
Berding, G.2
Kostler, H.3
-
52
-
-
7244260730
-
Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy
-
Weissenborn K, Krause J, Bokemeyer M, et al. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004 41 : 845 851.
-
(2004)
J Hepatol
, vol.41
, pp. 845-851
-
-
Weissenborn, K.1
Krause, J.2
Bokemeyer, M.3
-
53
-
-
0036156909
-
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease
-
Forton DM, Thomas HC, Murphy CA, et al. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002 35 : 433 439.
-
(2002)
Hepatology
, vol.35
, pp. 433-439
-
-
Forton, D.M.1
Thomas, H.C.2
Murphy, C.A.3
-
55
-
-
0035133903
-
Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C
-
Fontana RJ, Moyer CA, Sonnad S, et al. Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C. Am J Gastroenterol 2001 96 : 170 178.
-
(2001)
Am J Gastroenterol
, vol.96
, pp. 170-178
-
-
Fontana, R.J.1
Moyer, C.A.2
Sonnad, S.3
-
56
-
-
33947425672
-
The effects of HCV infection and management on health-related quality of life
-
DOI 10.1002/hep.21565
-
Younossi Z, Kallman J, Kincaid J. The effects of HCV infection and management on health-related quality of life. Hepatology 2007 45 : 806 816. (Pubitemid 46450632)
-
(2007)
Hepatology
, vol.45
, Issue.3
, pp. 806-816
-
-
Younossi, Z.1
Kallman, J.2
Kincaid, J.3
-
57
-
-
17144384773
-
Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C
-
Kraus MR, Schafer A, Csef H, Scheurlen M. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C. World J Gastroenterol 2005 11 : 1769 1774.
-
(2005)
World J Gastroenterol
, vol.11
, pp. 1769-1774
-
-
Kraus, M.R.1
Schafer, A.2
Csef, H.3
Scheurlen, M.4
|